Data for: Marrow Hypocellularity, but Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients with Morphologic Residual Disease
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Data set of outcomes based on day 14 bone marrow assessment.
创建时间：
2018-02-09
